Biotech

Partner Content

Partner Content

Overcoming bottlenecks in early drug discovery with the powe...

Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry

News

Amgen invests £50m in UK genetics firm Oxford Nanopore

Biotech giant Amgen has ploughed £50 million into a genetic sequencing company to support the development of its cutting-edge technology.

News

Crescendo hires ex-Roche R&D guru to develop T-cell technolo...

Biotech has already raised $70m this year in second funding round

R&D

DNA helix in a futuristic concept of the evolution of science and medicine.

UK regenerative medicine biotech appoints veteran 'drug hunt...

Biotech aims to wake up stem cells with small molecules to repair damaged tissues

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Market Access

Realising the biotech promise: addressing the path to market

Overview Now more than ever before, biotech is the engine for innovation in medicine, finding, creating and delivering ground-breaking treatments to patients.

News

UK biotech investor Arix looks for new CEO

UK biotech investor Arix Bioscience is looking for a new CEO after Joe Anderson decided to focus on running the investment side of the business and a reshuffle of its board.

Overcoming bottlenecks in early drug discovery with the powe...

Amgen invests £50m in UK genetics firm Oxford Nanopore

Crescendo hires ex-Roche R&D guru to develop T-cell technolo...

UK regenerative medicine biotech appoints veteran 'drug hunt...

Realising the biotech promise: addressing the path to market

UK biotech investor Arix looks for new CEO

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Biotech

Editor's Picks